[1] 马培奇.基因重组人胰岛素及其临床、市场与国内研发概况[J].中国医药情报,2001,7(3):32-35.
[2] 王凯.胰岛素的分类及临床应用[J].医学信息,2011,24(6):3814-3815.
[3] LEPORE M,PAMPANELLI S,FANELLI C,et al.Pharmacokinetics and pharmacodynamics of subcutaneous injection of long-acting human insulin analog glargine,NPH insulin,and ultralente human insulin and continuous subcutaneous infusion of insulin lispro[J].Diabetes,2000,49(12):2142-2148.
[4] COPPOLINO R,COPPOLINO S,VILLARI V.Study of the aggregation of insulin glargine by light scattering[J].Journal of Pharmaceutical Sciences,2006,95(5):1029-1034.
[5] 张守涛,梁会娟,张芸.人IGF-1在大肠杆菌中的可溶表达和纯化[J].生物技术,2010,20(2):14-16.
[6] 董文甫,李艳红,岳文斌.硫氧还蛋白研究进展[J].草食家畜,2006,4:4-6.
[7] NISHIHARA K,KANEMORI M,YANAGI H,et al.Overexpression of trigger factor prevents aggregation of recombinant proteins in Escherichia coli[J].Applied and Environmental Microbiology,2000,66(3):884-889.
[8] 崔硕硕,林学政,沈继红.分子伴侣共表达对低温脂肪酶Lip-837异源可溶性表达的影响[J].海洋科学进展,2011,29(1):105-111.
[9] XU H M,ZHANG G Y,JI X D,et al.Expression of soluble,biologically active recombinant human endostatin in Escherichia coli[J].Protein Expression and Purification,2005,41(2):252-258.
[10] DODSON G,STEINER D.The role of assembly in insulin's biosynthesis[J].Current Opinion in Structural Biology,1998,8(2):189-194.
[11] TANG J G,TSOU C L.The insulin A and B chains contain structural information for the formation of the native molecule.Studies with protein disulphide-isomerase[J].Biochem J,1990,268(2):429-435.
[12] WETZEL R,KLEID D G,CREA R,et al.Expression in Escherichia coli of a chemically synthesized gene for a "mini-c" analog of human proinsulin[J].Gene,1981,16(1):63-71.
[13] SUNG W L,YAO F L,ZAHAB D M,et al.Short synthetic oligodeoxyribonucleotide leader sequences enhance accumulation of human proinsulin synthesized in Escherichia coli[J].Proceedings of the National Academy of Sciences,1986,83(3):561-565.
[14] KANE J F,HARTLEY D L.Formation of recombinant protein inclusion bodies in Escherichia coli[J].Trends in Biotechnology,1988,6(5):95-101.
[15] THOMAS J G,AYLING A,BANEYX F.Molecular chaperones,folding catalysts,and the recovery of active recombinant proteins from E.coli[J].Applied Biochemistry and Biotechnology,1997,66(3):197-238.
[16] 陈阳,陈劲春.重组人胰岛素的体外复性纯化[J].北京化工大学学报:自然科学版,2009,36(1):77-80.
[17] 刘素丽,鲁勇,王学军,等.一种新型速效人胰岛素类似物的构建、制备及性质研究[J].东南大学学报:医学版,2009,28(5):371-375.
[18] ELLIS R J.The molecular chaperone concept//DAVEY J.Seminars in cell biology.London,UK:Academic Press,1990:1-9.
[19] 邱玉华,窦非.分子伴侣作为阿尔兹海默病治疗靶标的研究进展[J].东南大学学报:医学版,2011,30(3):522-525.
[20] KOBAYASHI H,YOSHIDA T,INOUYE M.Significant enhanced expression and solubility of human proteins in Escherichia coli by fusion with protein S from Myxococcus xanthus[J].Applied and Environmental Microbiology,2009,75(16):5356-5362.
[21] HUANG H R,DONG X,ZHANG Z D,et al.Co-expression of protein of mycobacterium tuberculosis with molecular chaperone[J].Tuber & Thor Tumor,2009(1):6-10. |